Results 11 to 20 of about 1,309,474 (364)

ADVANCES IN THE APPLICATION OF THE “VALVE-IN-VALVE” TECHNIQUE IN TRANSCATHETER AORTIC VALVE REPLACEMENT [PDF]

精准医学杂志, 2023
More and more biological valves have been used in aortic valve replacement in the world due to their unique advantages; however, due to the poor durability of biological valves and other reasons, valve deterioration is an inevitable problem of artificial
HE Yu, LIU Keqi, ZHANG Rong, LIU Xiaoyan, JIANG Lei
doaj   +1 more source

Effect of concurrent mitral valve surgery for secondary mitral regurgitation upon mortality after aortic valve replacement or coronary artery bypass surgery

Frontiers in Cardiovascular Medicine, 2023
ObjectivesIt is uncertain whether concurrent mitral valve repair or replacement for moderate or greater secondary mitral regurgitation at the time of coronary artery bypass graft or aortic valve replacement surgery improves long-term survival ...
Shyamal R. Asher, Chin Siang Ong, Raymond J. Malapero, Mahyar Heydarpour, Gregory W. Malzberg, Jasmine T. Shahram, Thy B. Nguyen, Douglas C. Shook, Stanton K. Shernan, Prem Shekar, Tsuyoshi Kaneko, Rodolfo Citro, Jochen D. Muehlschlegel, Simon C. Body   +13 more
doaj   +1 more source

Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.

New England Journal of Medicine, 2022
BACKGROUND Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may reduce the risk of stroke.
S. Kapadia, R. Makkar, Martin Leon, M. Abdel-Wahab, Thomas Waggoner, S. Massberg, W. Rottbauer, S. Horr, L. Søndergaard, J. Karha, R. Gooley, L. Satler, R. Stoler, S. Messé, S. Baron, J. Seeger, S. Kodali, A. Krishnaswamy, V. Thourani, K. Harrington, S. Pocock, R. Modolo, D. Allocco, I. Meredith, A. Linke   +24 more
semanticscholar   +1 more source

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

European Heart Journal, 2021
Aims The aims of the study were to compare clinical outcomes and valve durability after 8 years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk treated with either transcatheter aortic valve implantation (TAVI)
T. Jørgensen, H. Thyregod, N. Ihlemann, H. Nissen, P. Pétursson, B. J. Kjeldsen, D. Steinbrüchel, P. Olsen, L. Søndergaard   +8 more
semanticscholar   +1 more source

Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement

Journal of the American College of Cardiology, 2020
Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) and redo surgical aortic valve replacement (SAVR) represent the 2 treatments for aortic bioprosthesis failure. Clinical comparison of both therapies remains limited by the number of patients analyzed.The purpose of this study was to analyze the outcomes of VIV TAVR versus redo SAVR at a
Deharo, Pierre, Bisson, Arnaud, Herbert, Julien, Lacour, Thibaud, Etienne, Christophe Saint, Porto, Alizée, Theron, Alexis, Collart, Frederic, Bourguignon, Thierry, Cuisset, Thomas, Fauchier, Laurent   +10 more
openaire   +5 more sources

Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double‐blind, controlled trial

Pharmacology Research & Perspectives, 2021
The stability of hemodynamics during anesthesia induction in patients undergoing valve replacement surgery is particularly important. Remimazolam is a new type of benzodiazepine drug, with supposed advantages of rapid induction, rapid recovery, stable ...
Tianxi Liu, Ting-hai Lai, Jing Chen, Yizhi Lu, F. He, Yanhua Chen, Yubo Xie   +6 more
semanticscholar   +1 more source

A case of freestyle valve reoperation 23 years after the first operation

SAGE Open Medical Case Reports, 2022
We present a case of redo stentless valve operation in a 73-year-old man who underwent aortic valve replacement via the subcoronary approach with a freestyle aortic bioprosthesis 23 years ago at our institution.
Taiki Kawaida, Hiroaki Tanabe, Yuji Kato, Shintaro Yamazaki, Kimio Hosaka, Masaaki Toyama   +5 more
doaj   +1 more source

Immediate results of aortic valve replacement in elderly and senile patients using the Ozaki technique and Perceval S seamless biological prosthesis

Вестник хирургии имени И.И. Грекова, 2023
The OBJECTIVE was to compare the immediate results of aortic valve replacement using Perceval S seamless biological prosthesis and aortic valve replacement using Ozaki technique.METHODS AND MATERIALS.
D. G. Gramatikov, V. S. Litus, V. K. Noginov   +2 more
doaj   +1 more source

Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification.

Circulation, 2021
Use of transcatheter mitral valve replacement (TMVR) using transcatheter aortic valves in clinical practice is limited to patients with failing bioprostheses and rings or mitral valve disease associated with severe mitral annulus calcification.
M. Urena, A. Vahanian, E. Brochet, G. Ducrocq, B. Iung, D. Himbert   +5 more
semanticscholar   +1 more source

Sutureless vs. rapid-deployment valve: a systemic review and meta-analysis for a direct comparison of intraoperative performance and clinical outcomes

Frontiers in Cardiovascular Medicine, 2023
BackgroundSutureless and rapid-deployment valves are bioprostheses anchoring within the aortic annulus with few sutures, and they act as a hybrid of conventional surgical and transcatheter valves under aortic valve replacement.
Chenhao Wang, Yi Xie, Hongwei Zhang, Hongwei Zhang, Peng Yang, Peng Yang, Yu Zhang, Chen Lu, Yu Liu, Haiyue Wang, Zhenyuan Xu, Jia Hu, Jia Hu, Jia Hu   +13 more
doaj   +1 more source